• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT DIABETES CARE INC FREESTYLE LIBRE 2; FLASH GLUCOSE MONITORING SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT DIABETES CARE INC FREESTYLE LIBRE 2; FLASH GLUCOSE MONITORING SYSTEM Back to Search Results
Model Number 71992-01
Device Problem Device Alarm System (1012)
Patient Problems Hypoglycemia (1912); Sweating (2444); Confusion/ Disorientation (2553)
Event Date 10/08/2020
Event Type  Injury  
Manufacturer Narrative
Adc product quality engineering (pqe) investigated this alarm-2 (signal loss alarm) complaint.It was determined that the freestyle libre 2 sensor reported in this complaint was manufactured at flex buffalo grove (fbg) with the incorrect low temperature ratio parameter of zero (0).The low temperature ratio parameter setting should be set at 187.The incorrect low temperature ratio parameter will prevent the sensor bluetooth low-energy (ble) radio from enabling in the operational temperature range, and as a result the system will not be able to present glucose alarms.This failure mode was identified during investigation of the track and trend review related to alarm-2 cases in (b)(6) 2020.This issue was addressed in the field by adc fa1027-2020.Dhrs (device history review) for the freestyle libre sensor and freestyle libre sensor kit were reviewed and the dhrs showed the freestyle libre sensor and sensor kit passed all tests prior to release.The temperature ratio setting is in the machine software and therefore, not captured in the dhr.If the product is returned, a physical investigation will be performed and a follow-up report submitted.All pertinent information available to abbott diabetes care has been submitted.
 
Event Description
The customer reported a signal loss issue with the freestyle libre 2, which resulted in the low glucose alarm failing to trigger.The customer experienced symptoms of incoherent and sweating, and the sensor was reading 'lo' (< 40 mg/dl).The customer was treated with a glucose injection by his wife.There was no report of death or permanent injury associated with this event.
 
Manufacturer Narrative
Sensor (b)(4) was returned and investigated.A visual inspection was performed on the returned sensor patch and sensor plug assembly, no issues were observed.Sensor data was extracted using approved software and found to be in sensor state 5 (indicating normal termination).It was identified that the low-temperature ratio parameter was configured incorrectly to zero (0).This issue is therefore confirmed.
 
Event Description
The customer reported a signal loss issue with the freestyle libre 2, which resulted in the low glucose alarm failing to trigger.The customer experienced symptoms of incoherent and sweating, and the sensor was reading 'lo' (40 mg/dl).The customer was treated with a glucose injection by his wife.There was no report of death or permanent injury associated with this event.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
FREESTYLE LIBRE 2
Type of Device
FLASH GLUCOSE MONITORING SYSTEM
Manufacturer (Section D)
ABBOTT DIABETES CARE INC
1360 south loop road
alameda CA 94502 7001
MDR Report Key10711683
MDR Text Key212300210
Report Number2954323-2020-07679
Device Sequence Number1
Product Code QLG
Combination Product (y/n)N
PMA/PMN Number
K193371
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type consumer
Remedial Action Other
Type of Report Initial,Followup
Report Date 12/18/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Lay User/Patient
Device Expiration Date03/31/2021
Device Model Number71992-01
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer12/08/2020
Initial Date Manufacturer Received 10/12/2020
Initial Date FDA Received10/21/2020
Supplement Dates Manufacturer Received12/08/2020
Supplement Dates FDA Received12/18/2020
Is This a Reprocessed and Reused Single-Use Device? No
Removal/Correction NumberQR728102
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age70 YR
-
-